Ventilator-associated pneumonia in an intensive care unit: A comparative analysis of clinical and microbiological characteristics of COVID-19 and non-COVID-19 patients

Key Points

• This research aims to compare the clinical and microbiological characteristics of ventilator-associated pneumonia (VAP) in COVID-19 and non-COVID-19 patients.
• Comparative analysis of clinical data from COVID-19 and non-COVID-19 patients in an intensive care unit.
• Assessment of microbiological characteristics associated with VAP.
• Evaluation of treatment interventions including corticosteroid use.
• COVID-19 patients exhibit higher rates of acute respiratory distress syndrome (ARDS) and corticosteroid treatment.
• COVID-19-associated VAP shows a greater prevalence of multidrug-resistant organisms compared to non-COVID-19 cases.
• Individualized antimicrobial strategies are suggested to reduce morbidity and mortality.